Such insights would help us to understand the virulence and immune evasion mechanisms of malaria parasites, and explore the possibility of developing a genetically attenuated blood-stage vaccine for malaria if HMGB1 deletion can lead to self-clearance and protection for human parasites. The gene discussed is HMGB1; the disease is malaria.